Orange Book product · Brand (NDA)
INTERMEZZO
ZOLPIDEM TARTRATE
At a glance
Nov 23, 2011
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 23, 2011
14 yr 9 mo ago
Today
Patent 7658945 expires
Listed drug product patent expiration.
Apr 15, 2027
in 10 mo
Patent 8242131 expires
Listed method-of-use patent (U-1266) expiration.
Aug 20, 2029
in 3 yr 3 mo
Pharmaceutical detail
Active ingredient
ZOLPIDEM TARTRATE
Strength
1.75MG
Dosage form
TABLET
Route
SUBLINGUAL
TE code
Not listed
Application
NDA 022328
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023ZOLPIDEM TARTRATEBrand (NDA)
NDA 215721 · ALMATICA
- 2009EDLUARBrand (NDA)
NDA 021997 · VIATRIS
- 2008ZOLPIMISTBrand (NDA)
NDA 022196 · AYTU
- 2007TOVALT ODTBrand (NDA)
NDA 021412 · BIOVAIL LABS INTL
- 2005AMBIEN CRBrand (NDA)
NDA 021774 · COSETTE
- 1992AMBIENBrand (NDA)
NDA 019908 · COSETTE
- 2026ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 220717 · UMEDICA LABS PVT
- 2020ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 213592 · BRECKENRIDGE
- 2017ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204229 · PH HEALTH
- 2017ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204170 · SUN PHARM
- 2016ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204503 · DR REDDYS
- 2016ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 202657 · PHARMOBEDIENT
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7658945 | Apr 15, 2027 | in 10 mo | ProductU-1194 |
| 8242131 | Aug 20, 2029 | in 3 yr 3 mo | U-1266 |

